Clinical Trials on Light Chain (AL) Amyloidosis
Total 159 results
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAmyloidosis | Immunoglobulin Light Chain Deposition
-
IRCCS Policlinico S. MatteoRecruitingAL AmyloidosisGermany, Italy, Spain, Switzerland, Netherlands
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruiting
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
National Cancer Institute (NCI)Recruiting
-
IRCCS Policlinico S. MatteoRecruiting
-
Emory UniversityNational Cancer Institute (NCI); SanofiActive, not recruitingAL AmyloidosisUnited States
-
Alexion Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterVanderbilt University Medical Center; Tufts Medical CenterActive, not recruiting
-
Oncopeptides ABPRA Health SciencesTerminatedAL AmyloidosisSpain, United Kingdom, Germany, Norway, Israel, France, United States, Czechia, Greece
-
University Hospital, LimogesCompletedAmyloidosisFrance, Italy
-
University College, LondonCompleted
-
Boston Medical CenterCelgene CorporationCompletedAL AmyloidosisUnited States
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
University of TennesseeCompleted
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
Stanford UniversityCelgene CorporationCompletedLeukemia | AmyloidosisUnited States
-
Prothena Biosciences Ltd.CompletedAL AmyloidosisUnited States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
-
Regeneron PharmaceuticalsNot yet recruitingRelapsed/Refractory Systemic Light Chain Amyloidosis
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
IRCCS Policlinico S. MatteoWithdrawnPrimary Amyloidosis of Light Chain TypeItaly
-
IRCCS Policlinico S. MatteoRecruiting
-
Prothena Biosciences Ltd.Amyloidosis Research Consortium; Amyloidosis Support Groups; Amyloidosis Foundation and other collaboratorsCompletedAL Amyloidosis | AmyloidosisUnited States
-
M.D. Anderson Cancer CenterCelgeneTerminatedMyelomaUnited States
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Marianna FontanaRecruitingExploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders (EXACLIBUR)Sudden Cardiac Death | Arrythmia | Cardiac Amyloidosis | Systemic AL AmyloidosisUnited Kingdom
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Fondazione Toscana Gabriele MonasterioRecruitingAmyloid | Amyloid CardiomyopathyItaly
-
Jian LiPeking University First Hospital; Tongji Hospital; Nanfang Hospital of Southern... and other collaboratorsCompletedAmyloidosis; SystemicChina
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Japan, Belgium, Greece, Australia, Austria, Brazil, Canada, China, Czechia, Israel, Italy, Russian Federation
-
Nanjing University School of MedicineRecruitingLight Chain AmyloidosisChina
-
Midwest Heart & Vascular SpecialistsRecruitingAL Amyloidosis | Amyloid | Cardiac Amyloidosis | Amyloidosis Cardiac | Systemic Amyloidosis | ATTR Amyloidosis Wild Type | Infiltrative Cardiomyopathy, AmyloidUnited States
-
Boston Medical CenterCompleted
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
The Cleveland ClinicCompletedAmyloidosis | Spinal Stenosis | Amyloid | Transthyretin Amyloidosis | Primary Amyloidosis of Light Chain TypeUnited States
-
Nanjing University School of MedicineEnrolling by invitationAL Amyloidosis | Plasma Cell DyscrasiaChina
-
The Cleveland ClinicCompletedAmyloidosis | Transthyretin Amyloidosis | Trigger Finger | Primary Amyloidosis of Light Chain TypeUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMultiple Myeloma | AL AmyloidosisUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
National Cancer Institute (NCI)TerminatedPrimary Systemic AmyloidosisUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingMultiple Myeloma | AL Amyloidosis | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell DyscrasiasUnited States
-
Tufts Medical CenterNational Institute on Aging (NIA)CompletedMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Tufts Medical CenterCompletedPlasma Cell Dyscrasia | Monoclonal GammopathyUnited States
-
Tufts Medical CenterNational Cancer Institute (NCI)Not yet recruitingSmoldering Multiple MyelomaUnited States
-
The Cleveland ClinicCompletedPrimary Systemic Amyloidosis